Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA

被引：42
作者：
Tomiyama, M
Kimura, T
Maeda, T
Tanaka, H
Kannari, K
Baba, M
机构：
[1] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Neurol Sci, Hirosaki, Aomori 0368216, Japan
[2] Hirosaki Univ, Sch Med, Dept Med 3, Hirosaki, Aomori 0368216, Japan
来源：
SYNAPSE | 2004年 / 52卷 / 03期
关键词：
Parkinson's disease; dyskinesia; striatum; dopamine; priming;
D O I：
10.1002/syn.20011
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
To determine whether the adenosine A(2A) receptor might play a role in L-DOPA-induced dyskinesia in Parkinson's disease, we analyzed changes in the expression of A(2A) receptor mRNA in response to intermittent treatment with L-DOPA in rats with dopaminergic denervation by 6-hydroxydopamine (OHDA) infusion into the medial forebrain bundle. Intermittent treatment with L-DOPA increased A(2A) receptor mRNA levels in the dopamine-depleted striatum of 6-OHDA-lesioned rats exhibiting behavioral sensitization to L-DOPA. These results suggest that A(2A) receptor activation is associated with the development of motor complications induced by L-DOPA treatment. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码：218 / 222
页数：5
相关论文
共 31 条
  • [1] Adenosine A2A receptor antagonist treatment of Parkinson's disease
    Bara-Jimenez, W
    Sherzai, A
    Dimitrova, T
    Favit, A
    Bibbiani, F
    Gillespie, M
    Morris, MJ
    Mouradian, MM
    Chase, TN
    [J]. NEUROLOGY, 2003, 61 (03) : 293 - 296
  • [2] REVERSAL OF EXPERIMENTAL PARKINSONISM BY LESIONS OF THE SUBTHALAMIC NUCLEUS
    BERGMAN, H
    WICHMANN, T
    DELONG, MR
    [J]. SCIENCE, 1990, 249 (4975) : 1436 - 1438
  • [3] Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats
    Carta, AR
    Pinna, A
    Cauli, O
    Morelli, M
    [J]. SYNAPSE, 2002, 44 (03) : 166 - 174
  • [4] Adenosine A(2A) receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats
    Fenu, S
    Pinna, A
    Ongini, E
    Morelli, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 321 (02) : 143 - 147
  • [5] Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors
    Fredduzzi, S
    Moratalla, R
    Monopoli, A
    Cuellar, B
    Xu, K
    Ongini, E
    Impagnatiello, F
    Schwarzschild, MA
    Chen, JF
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (03) : 1054 - 1062
  • [6] Fredholm BB, 2001, PHARMACOL REV, V53, P527
  • [7] Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
    Grondin, R
    Bédard, PJ
    Tahar, AH
    Grégoire, L
    Mori, A
    Kase, H
    [J]. NEUROLOGY, 1999, 52 (08) : 1673 - 1677
  • [8] Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease
    Henry, B
    Brotchie, JM
    [J]. DRUGS & AGING, 1996, 9 (03) : 149 - 158
  • [9] Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease
    Henry, B
    Crossman, AR
    Brotchie, JM
    [J]. EXPERIMENTAL NEUROLOGY, 1998, 151 (02) : 334 - 342
  • [10] CONTINUOUS AND INTERMITTENT LEVODOPA DIFFERENTIALLY AFFECT BASAL GANGLIA FUNCTION
    JUNCOS, JL
    ENGBER, TM
    RAISMAN, R
    SUSEL, Z
    THIBAUT, F
    PLOSKA, A
    AGID, Y
    CHASE, TN
    [J]. ANNALS OF NEUROLOGY, 1989, 25 (05) : 473 - 478
1234